SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tong-Chun Xue, Bo-Heng Zhang, Sheng-Long Ye, Zheng-Gang Ren, Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis, Tumor Biology, 2015,

    CrossRef

  2. 2
    Lina Prasmickaite, Gisle Berge, Ingrid J. Bettum, Steinar Aamdal, Johan Hansson, Lars Bastholt, Miriam Øijordsbakken, Kjetil Boye, Gunhild M. Mælandsmo, Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial, Cancer Immunology, Immunotherapy, 2015,

    CrossRef

  3. 3
    Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng, Heterogeneity of hepatocellular carcinoma contributes to cancer progression, Critical Reviews in Oncology/Hematology, 2015,

    CrossRef

  4. 4
    Junli Wang, Legen Nong, Yesheng Wei, Shanyu Qin, You Zhou, Yujin Tang, Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk, Human Immunology, 2014, 75, 1, 76

    CrossRef

  5. 5
    Yanzhang Hao, Jianwei Liu, Ping Wang, Feng Wang, Zeshun Yu, Mianli Li, Shaoshui Chen, Fangling Ning, OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC, International Journal of Genomics, 2014, 2014, 1

    CrossRef

  6. 6
    Lunxiu Qin, Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies, Frontiers of Medicine, 2014, 8, 1, 24

    CrossRef

  7. You have free access to this content7
    Sumiko Nagoshi, Osteopontin: Versatile modulator of liver diseases, Hepatology Research, 2014, 44, 1
  8. 8
    Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee, John M Luk, Circulating markers for prognosis of hepatocellular carcinoma, Expert Opinion on Medical Diagnostics, 2013, 7, 4, 319

    CrossRef

  9. 9
    Giovanni Musso, Elena Paschetta, Roberto Gambino, Maurizio Cassader, Federica Molinaro, Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver, Trends in Molecular Medicine, 2013, 19, 9, 522

    CrossRef

  10. 10
    Ane Rud, Kjetil Boye, Miriam Øijordsbakken, Marius Lund-Iversen, Ann Halvorsen, Steinar K Solberg, Gisle Berge, Åslaug Helland, Odd Brustugun, Gunhild M Mælandsmo, Osteopontin is a prognostic biomarker in non-small cell lung cancer, BMC Cancer, 2013, 13, 1, 540

    CrossRef

  11. 11
    Yu Fan, Xu Zhang, Zhi-Hui Yang, Xing-Wang Sun, Shi-Ning Li, Li Zhong, Xu Cheng, Yu Wang, Yue-Rong Ma, The Polymorphisms of Osteopontin Gene and Plasma Osteopontin Protein Levels with Susceptibility to Colorectal Carcinoma, DNA and Cell Biology, 2013, 32, 10, 594

    CrossRef